Log in
Enquire now
‌

US Patent 7906130 Amitraz compositions

Patent 7906130 was granted and assigned to Wyeth on March, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
1

Patent attributes

Current Assignee
Wyeth
Wyeth
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
79061301
Patent Inventor Names
Jacob A. Zupan1
Shobhan Shashi Sabnis1
Robert Bruce Albright1
Date of Patent
March 15, 2011
1
Patent Application Number
112455791
Date Filed
October 7, 2005
1
Patent Citations Received
‌
US Patent 11752137 Ophthalmic compositions for treating ocular
‌
US Patent 11690827 Methods for treating ocular
2
‌
US Patent 11690826 Methods for treating demodex blepharitis using lotilaner formulations
3
Patent Primary Examiner
‌
Johann R. Richter
1
Patent abstract

The present invention provides a stable composition which comprises a non-hydroxyl-group-containing solvent mixture comprising N,N-diethyl-m-toluamide and γ-hexalactone, optionally with dimethyl sulfoxide, eucalyptol and 1-methoxy-2-propyl acetate; and an effective amount of each of amitraz and at least one additional parasiticidal compound, such as R-28153. Said composition allows for high concentrations of a mixture of parasiticidal agents in a single application and is useful for treating and controlling parasiticidal infection and infestation in a homeothermic animal.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7906130 Amitraz compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.